University of Iowa and Holden Comprehensive Cancer Center — Iowa City, Iowa

University of Iowa and Holden Comprehensive Cancer Center is a clinical research site located in Iowa City, Iowa, United States 52242.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Iowa and Holden Comprehensive Cancer Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence.

Sponsors: Arsenal Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Iowa City

Browse all research sites in Iowa · View every site in Iowa City

• University of Iowa Hospitals and Clinics, 200 Hawkins Dr, Iowa City, IA 52242
• University of Iowa, Roy J and Lucille A Carver College of Medicine
• University of Iowa Hospitals, 2133 Rcp Department of Neurology, 200 Hawkins Drive
• VA Iowa City Healthcare system
• University of Iowa Dept. of Neurology
• Iowa City VA Medical Center
• University of Iowa Health Care Medical Center
• University of Iowa-Cancer Center Research
• University of Iowa Hospitals and Clinics 200 Hawkins Drive (Site 840023)
• University of Iowa Hospital
• Iowa City VA Healthcare System
• University of Iowa Hospitals and Clinics/ Internal Medicine

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Iowa and Holden Comprehensive Cancer Center?

University of Iowa and Holden Comprehensive Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Iowa and Holden Comprehensive Cancer Center conducted?

University of Iowa and Holden Comprehensive Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence.

Is University of Iowa and Holden Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

University of Iowa and Holden Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Iowa and Holden Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.